Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis
Lists
Only you see this
Abstract
MZR is well tolerated and has an effect similar to MMF in the induction therapy of active LN. MZR may serve as an alternative approach for LN patients.
BibTeX
@inproceedings{feng2014mizoribine,
author = {Xuebing Feng and Fei Gu and Weiwei Chen and Yan Liu and Wei Hua and Lin Liu and Songlou Yin and Zhanyun Da and Lingyun Sun},
title = {{Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis}},
booktitle = {Chinese},
year = {2014},
doi = {10.3760/cma.j.issn.0366-6999.20140627},
}Loading related content...